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The topic of NABC’s annual meeting, held in Chicago on May 22–24, 2001, was
“High Anxiety and Biotechnology: Who’s Buying, Who’s Not, and Why?” The
organizers had some anxiety of their own when they realized that the meeting
was a likely target for anti-GMO protestors, and these groups did appear on the
first day of the conference. But all was peaceful, and the street theater even did
us a favor by attracting the media. NABC 2001 participants provided several
media interviews, which were broadcast both locally and on an agricultural
television network.
The meeting used an optical metaphor to represent the divergent viewpoints
of participants in the public GMO debate. Each plenary session examined the
subject as focused through a different kind of lens. This centered the GMO
debate on the context of its participants and emphasized that not all judge the
issue from a single vantage point.
LESSONS TO LEARN FROM
Five plenary speakers set the stage and established perspective for the meeting.
Michael Jacobson from the Center for Science in the Public Interest, pointed
out the potential benefits of agricultural biotechnology, not just for farmers, but
also for consumers and the environment. He reminded the audience that public
outcry has brought biotechnology to a crossroads, and he cautioned against
extreme views on either side. Those who claim that all applications of
agricultural biotechnology are bad fall into one kind of trap, but those who
assert that biotechnology will provide all the answers fall into another. Jacobson
believes that objective parties, including universities and state and federal
agencies, ought to be doing more research on behalf of agricultural producers.
Napoleon Juanillo from the University of Illinois pointed out gaps between
the way that scientists tell their story and the expectations of the public.
Researchers avoid eloquence and speak plainly. They are cautious, hesitant to
extrapolate, and generally unprepared to deliver sound bites. Increasingly,
though, the public is interested in the subjective and in nuance. Is agricultural
biotechnology moral? Is it fair, or does it exploit? Does it cause society to lose
control? People expect these issues to be addressed, and it is especially difficult
for scientists to do so.
We heard about pasteurization as a case study in new technology and the
complications that surround technological change. Joseph Hotchkiss from
Cornell University surprised many in the audience by reminding us that the
technology of heating milk to kill bacteria—a benign process by today’s
standards—was vigorously resisted in the late nineteenth and early twentieth
centuries. As a consequence, infant mortality remained high for decades after
the invention of a process to make milk safe. This historical lesson was
sobering, especially to those who view biotechnology as an important tool to
combat world hunger.
Nancy Millis from the University of Melbourne challenged participants with
a thoughtful analysis of risk and its management. Who decides which risks are
acceptable and which are not? She reminded us that scientists were allowed to
make these decisions in the past, but that society now demands a voice in the
process. One of her key take-home messages is that perceptions of hazard must
be taken seriously. Australia’s experience with GM crops provided several
examples of governmental activities to inform both growers and the general
public.
C. S. Prakash from Tuskegee University told the story of agricultural
biotechnology and its historical roots. The continuum of agricultural
improvements over the centuries—beginning with simple selection and now
involving biotechnology—represents a success story and a source of pride for
many in the audience. But it is difficult for the public to appreciate either the
historical context or the future potential for agricultural biotechnology. Instead,
people want the unattainable: zero risk. Consumer perception of risk with foods
is no different from that with any other kind of change, but this fact is small
comfort for those seeking to educate the general public.
INFLUENCING THE CONSUMER LENS
Session II helped us to understand how consumer attitudes can be influenced.
Kerry Smith from North Carolina State University provided lessons on the basis
of his experience with health risks. One of these, radon gas, can seep into home
basements and represents an involuntary risk. If local governments want people
to monitor for this gas, impersonal campaigns with notices and posters are
ineffective. But as soon as community leaders become involved in educational
efforts, citizens begin to respond. The message for biotechnology: Continuous,
personalized involvement can make a difference. Efforts to educate on the
hazards of smoking provide another perspective: Be honest, build trust, and be
aware of the fact that people become very concerned when the results of the
choices they make are irreversible.
Mark Sagoff from the University of Maryland showed us evidence that food
processors deliberately and broadly offer food as fantasy, with liberal use of
natural in advertising. This was an important message to those who sometimes
feel that consumers are conditioned to fantasize only about the products of
biotechnology. Sagoff convulsed the audience with colorful Shakespearean
imagery of the concept of natural.
DIVERGENT LENSES OF STAKEHOLDERS
The most all-encompassing session emphasized the rich diversity of partici-
pants in the agricultural biotechnology debate. Dave Erickson, a northwest
Illinois farmer, gave us a poignant first-person account of agricultural
biotechnology from the viewpoint of a midwestern producer of corn and
soybean. This perspective is often overlooked by consumers and by those
interested in trade and public policy. To farmers, though, biotechnology is
primarily a management tool that will be accepted if it makes economic sense.
Anatole Krattiger from bioDevelopments LLC considered the potential for
biotechnology to solve problems in the developing world, but with several
unique perspectives on globalization. One is the sheer speed with which the
technology has been advanced by the private sector and adopted in the
developed world. This has caught scientists off guard and mystified some of
those interested in improving the human situation. Application of agricultural
biotechnology to the developing world has challenged our concepts of
intellectual property and the perceived role of public research establishments
dedicated to fighting hunger. Krattiger advocates a novel “privic” approach that
involves both the private and public sectors.
Tony Van der haegen’s after-dinner keynote address offered a view from the
European Union, one that underscored the importance of food safety to
European consumers who enjoy abundant food supplies and thus the luxury to
make food choices. We were reminded that Americans must understand the
psychological undercurrents to the debate in Europe. Europeans are more
cautious about new technology and the influence of large corporations. And,
unlike Americans, they have recently experienced food and health scandals
involving mad cow disease and tainted blood supplies that have eroded trust in
scientists and regulators. Lack of understanding between the United States and
Europe has already disrupted trade. Ongoing thorny debates about regulatory
approval and labeling are not likely to be settled in the near future. However,
Van der haegen projected that Europe will eventually accept biotechnology-
based foods.
Dirk-Arie Toet from Nestlé gave us a personalized and industry view from the
European standpoint. Although Americans often view the European situation
pessimistically, Toet pointed out that politicians are again speaking publicly
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about biotechnology. He summarized plans for a new European framework for
discussions, particularly as they apply to tracing and labeling.
Gary Comstock from Iowa State University, who sometimes used audience
members as examples in thought games, helped us to organize our ethical
thoughts about agricultural biotechnology. The audience learned to distinguish
factual assertions from value-laden, normative assertions—and extrinsic
objections to the introduction of biotechnology from intrinsic objections that
the process itself is in some way harmful.
Susan Harlander from BIOrational Consultants was unable to attend the
meeting. Bruce Chassy from the University of Illinois summarized her
perspective from the standpoint of the food industry. On the one hand, the
United States Food and Drug Administration considers GM crops to be
“substantially equivalent” to their traditional counterparts. This means that
they can be managed simply as commodities in this country. On the other hand,
various sorts of labeling are required in many other countries, and so food
companies doing business worldwide must comply with various sorts of
regulations. Consequently, food companies have removed GM ingredients in
countries with mandatory labeling requirements. These conflicts have led to
turmoil in the marketplace. Harlander pleads for harmonization of the
regulatory process across international boundaries.
At the final lunch-time session, Stanley Abramson from Arent Fox Kintner
Plotkin & Kahn, PLLC, in Washington, DC, shared his recommendations for
improving product stewardship and federal regulations.
FINAL REMARKS
NABC 2001 was not just about plenary sessions. As a prelude to the traditional
annual conference workshops, we were treated to a rollicking great debate that
was moderated by NABC President Ralph Hardy. Featured were two unnamed
members of the organizing committee. One was in white lab coat, scrolling
really bad slides and pontificating about technology. The other, who was deeply
buried under a fright wig, took the role of protestor. The dialogue ran its
expected course and ended with hotel security “escorting” the activist from
the room.
Tom Hoban’s “Hot Topics and Hot Hors D’Oeuvres” provided another change
of pace. Tom shared some of his research data on consumer perceptions of
biotechnology and then invited meeting participants to comment. The
atmosphere was informal and cozy, the subject matter was challenging, and the
wine and food worked their magic. This session ended, not when Tom sat
down, but when the hotel staff turned off the lights.
“High Anxiety,” which attracted more than 200 scientists and leaders in the
agricultural and food arenas, was organized by the University of Illinois and
Iowa State University. The annual NABC meeting always attracts a diversity of
speakers and speaking styles, but rarely have the participants had so much fun,
mixing laughter with challenging thoughts on agricultural biotechnology.
